Food Triggers Creation of Regulatory T Cells IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.Counting Cancer-busting Oxygen Molecules Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.Crowdfunding the Fight Against Cancer From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Keeping Tumor Growth at Bay Engineers at Washington University in St. Louis found a way to keep a cancerous tumor from growing by using nanoparticles of the main ingredient in common antacid tablets.Cancer Cells Kill Off Healthy Neighbours Cancer cells create space to grow by killing off surrounding healthy cells, according to UK researchers working with fruit flies.Future of Medicine Could be Found in a Tiny Crystal Ball A Drexel University materials scientist has discovered a way to grow a crystal ball in a lab. Not the kind that soothsayers use to predict the future, but a microscopic version that could be used to encapsulate medication in a way that would allow it to deliver its curative payload more effectively inside the body.Bile Acid Supports Production of Blood Stem Cells A research group at Lund University has been able to show that bile acid is transferred from the mother to the foetus via the placenta to enable the foetus to produce blood stem cells.Chemical Used to Replace BPA is Potentially Toxic This study is the first to examine the effects of BPA and BPS on brain cells and genes that control the growth and function of organs involved in reproduction.A Better Model for Parkinson's Scientists at EPFL solve a longstanding problem with modeling Parkinson’s disease in animals. Using newfound insights, they improve both cell and animal models for the disease, which can propel research and drug development.Improving Delivery of Poorly Soluble Drugs Using Nanoparticles A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.
Lab-on-Chip Platform Technologies for Point-of-Care Testing and Cell Culturing This presentation focuses on recent advances in platform technologies developed at Micronit for applications within point-of-care diagnostics and cell culturing. A few examples developed within research projects are presented to illustrate the applicability of the developed technologies.
Managing Pharmaceutical Lab Data Management to Ensure Compliance Join Stacey Brown and William Leonard, Senior Validation Analysts for Informatics at Thermo Fisher Scientific, to understand more about the complex requirements of pharmaceutical data management.
Translation of Omic Data into Personalised Oncology Tools The Challenge and the Reward William Gallagher, University College Dublin, speaking at Diagnostics & Biomarkers 2015.
Comprehensive Integration, Automation and Parallelisation of Multi-step Bioanalytical Assay Formats on the Centrifugal Microfluidic Lab-on-a-Disc Platform Jens Ducree, Biomedical Diagnostics Institute/Dublin City University, speaking at Lab-on-a-Chip & Microfluidics 2015
Parallel Tracking i-biomarkerT Development with Drug Development for Maximum Benefit Kevin Cox, Imanova Limited, speaking at Diagnostics & Biomarkers.
Drug Sensitivity and Resistance Testing Platform for Personalized Medicine at the Institute for Molecular Medicine Finland (FIMM) Jani Saarela, Institute for Molecular Medicine, speaking at Screening Europe 2015
The Application of a Resonant Coil Magnetometer for Point of Care Diagnostic Applications Richard Luxton, University of the West of England, speaking at Point of Care Diagnostics 2015
Discovery of Potent and Selective Inhibitors of Monopolar Spindle 1 (MPS1) Kinase Rob van Montfort, The Institute of Cancer Research, speaking at Discovery Chemistry Congress 2015.
Mass spectrometry based metabolomics in chemical and nanomaterial risk assessment In this webinar, Mark Viant, Professor of Metabolomics at the University of Birmingham, will introduce the concepts of metabolomics as well as the challenges faced in chemical hazard assessment.
A Structured Approach to Academic Drug Discovery Simon Ward, University of Sussex, speaking at Discovery Chemistry Congress 2015